LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Lucid Diagnostics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.38−0.10 (-21.05%)
Close on Oct 19, 2026
- Market cap
- $69.11M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Lucid Diagnostics has not reported a dividend
No dividend per share appears in Lucid Diagnostics's annual filings since fiscal 2019.